Solid Biosciences Inc. - Director's Dealing 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-01-27

Reporting Person: Ganot Ilan (Director, CEO & President)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-27	Employee Stock Option (Right to Buy)	$1.13	A	466000	Acquired	2032-01-27	Common Stock (466000)	Direct
2022-01-27	Restricted Stock Units	$	A	233000	Acquired		Common Stock (233000)	Direct
2022-01-27	Employee Stock Option (Right to Buy)	$1.13	A	46400	Acquired	2032-01-27	Common Stock (46400)	Indirect
2022-01-27	Restricted Stock Units	$	A	23300	Acquired		Common Stock (23300)	Indirect

F1: This option was granted on January 27, 2022 and vests in four equal annual installments on the anniversary of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.

F3: The restricted stock units were granted on January 27, 2022 and vest on the same schedule as set forth in footnote (1) above.